Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN), a leader in the development of next-generation mental health treatments, has announced that its CEO, Doug Drysdale, will participate in a fireside chat at the Canaccord Genuity 45th Annual Growth Conference. Scheduled for August 12, 2025, in Boston, this event will spotlight Cybin's pioneering work in neuropsychiatry, particularly its efforts to address the significant unmet needs in mental healthcare.
The presentation, which will be webcast live at 2:30 p.m. ET, offers investors and the public a closer look at Cybin's clinical-stage developments, including CYB003 and CYB004. These proprietary compounds represent a new frontier in the treatment of major depressive disorder and generalized anxiety disorder, respectively. With mental health conditions affecting millions worldwide, Cybin's research could herald a new era of treatment options that offer long-lasting relief with fewer doses.
For those interested in the future of mental health treatment, the conference provides a unique opportunity to hear directly from Cybin's leadership about the company's direction and the science behind its innovative approaches. An archived version of the webcast will be available on Cybin's investor relations site, ensuring broader access to this potentially transformative information.
Cybin's commitment to revolutionizing mental healthcare is evident in its extensive research pipeline and its operational presence across multiple countries. By focusing on intermittent treatments that promise enduring results, Cybin is challenging traditional paradigms in mental health treatment. The company's work, particularly on compounds like CYB003 and CYB004, could significantly impact the lives of individuals suffering from mental health conditions, offering hope where traditional treatments have fallen short.
For more details on Cybin's participation in the Canaccord Genuity Growth Conference, visit https://ibn.fm/6xavA. To learn more about Cybin's groundbreaking work in neuropsychiatry, visit https://www.cybin.com.
